Risk Management & Pharmacovigilance

PV100
- August 01, 2017
Annette Stemhagen, DrPH, FISPE, Vice President, Safety, Epidemiology, Registries & Risk Management, goes the extra mile for clients, working to improve drug safety and patient access to therapies. She has more than 30 years of...
Tagged in:
New social media technology is opening the lines of communication for patients
- July 31, 2017
Professionals working in the field of Pharmacovigilance traditionally collect and assess reports of potential adverse events based on information received from healthcare providers’ interactions with patients. In addition, pharma...
- July 03, 2017
During DIA’s Annual Meeting, June 18-22, in Chicago, the UBC team met hundreds of like-minded professionals, across dozens of disciplines, all focused on the goal of gaining and sharing knowledge to improve healthcare. We know that...
Don't miss our DIA preconference tutorial on REMS Assessment Reports
- June 01, 2017
Creating a REMS assessment report requires a high-functioning, coordinated team effort, often involving numerous departments and external vendors. UBC’s REMS experts have designed, implemented, and/or evaluated more than 100 RiskMAPS...
Tagged in:
Our EU risk management experts provide insights on the new EMA guidance.
Janine Collins, MBBS, LLM, Sr. Director, European Risk Management, and Dafna Bonneh-Barkay, PhD, MSc, Sr. Project Manager - April 03, 2017
Introduction On Friday, 31 March 2017 the EMA released the revised Module V- Risk Management Systems (Rev 2) of Good Pharmacovigilance Practice (GVP) (EMA/838713/2011 Rev 2) accompanied by a revised Guidance on the format of the...
Tagged in:

Pages